Product NDC: | 0469-3525 |
Proprietary Name: | Vibativ |
Non Proprietary Name: | telavancin hydrochloride |
Active Ingredient(s): | 250 mg/1 & nbsp; telavancin hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0469-3525 |
Labeler Name: | Astellas Pharma US Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022110 |
Marketing Category: | NDA |
Start Marketing Date: | 20091105 |
Package NDC: | 0469-3525-30 |
Package Description: | 10 CONTAINER in 1 CARTON (0469-3525-30) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CONTAINER |
NDC Code | 0469-3525-30 |
Proprietary Name | Vibativ |
Package Description | 10 CONTAINER in 1 CARTON (0469-3525-30) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CONTAINER |
Product NDC | 0469-3525 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | telavancin hydrochloride |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20091105 |
Marketing Category Name | NDA |
Labeler Name | Astellas Pharma US Inc. |
Substance Name | TELAVANCIN HYDROCHLORIDE |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes |